CPRX - Catalyst Corp Kapitalizatsiyaning sotish hajmiga nisbati
Catalyst Pharmaceuticals qat'iy FDA nazoratiga qaramay, patentlar va lobbiistlar ko'magi orqali noyob nevropatologiya nishasida dominantlikni saqlab qolmoqda. O'sish yangi aktivlarni sotib olish va eksklyuziv dori vositalarini monetizatsiya qilish hisobiga ta'minlanmoqda. Joriy P/S tendentsiyasi kapitalizatsiyaning savdoga nisbatdagi bozor bahosini aniq ko'rsatadi, bunda ko'rsatkich 6.40 ga yetadi. Logistika samaradorligi avtomatlashtirilgan dasturiy ta'minot va robotlashtirilgan qadoqlashni joriy etish orqali ta'minlanadi.
Catalyst Pharmaceuticals Inc (CPRX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi haqida ma'lumot:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Catalyst Pharmaceuticals|CPRX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Catalyst Corp|CPRX - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Catalyst Pharmaceuticals Inc|CPRX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Catalyst Pharmaceuticals|Tezkor likvidlik koeffitsiyenti catalystpharma.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
CPRX - Sof foyda|Kelajakdagi foyda Catalyst Pharmaceuticals|CPRX - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Catalyst Pharma|CPRX - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Catalyst Pharmaceuticals Inc|CPRX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Catalyst Pharmaceuticals|CPRX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi catalystpharma.com|CPRX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Catalyst Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:catalystpharma.com, CPRX
P/S koeffitsiyenti Catalyst Pharmaceuticals (CPRX) bozor qiymatini uning savdo hajmi bilan taqqoslaydi va investorlar hozirda daromadning har bir birligi uchun qancha narx belgilayotganini ko'rsatadi. Narx-savdo tendentsiyasini tahlil qilish orqali kompaniyaning dori vositalari bozoridagi monopoliya maqomi uchun qo'shimcha to'lovni baholash mumkin, bu esa uzoq muddatda biofarmatsevtika biznesining barqaror pul oqimlarining yuqori bozor qiymatini tasdiqlaydi.
Catalyst Pharmaceuticals raqobatchilari
Narx/daromad koeffitsiyenti biogen.com|Neurocrine Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati RGC (Regencell Bioscience Ltd)|AXSM: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|Narxning sotuvga nisbati VKTX (vikingtherapeutics.com)|SUPN (Supernus) - P/S multiplikatori|DNLI: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HRMY|P/S multiplikatori Biohaven Corp (BHVN)|Narxning daromadga nisbati Amylyx Pharmaceuticals AMLX|Bozor kapitallashuvining daromadga nisbati TRVI|PRAX - Narxning daromadga nisbati|Anavex (AVXL) - Kapitalizatsiyaning daromadga nisbati|CBLL: P/S multiplikatori|Prothena Corp (PRTA) - P/S multiplikatori|ALEC (Alector Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati annexonbio.com (ANNX)|P/S multiplikatori OMER|NGNE - Sotuvga nisbatan narx|AC Immune Corp - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Voyager Corp VYGR|NMRA: Kapitalizatsiyaning daromadga nisbati|scilexholding.com - Kapitalizatsiyaning sotish hajmiga nisbati|TVGN: P/S multiplikatori|ACOG - Narx/daromad koeffitsiyenti|CGTX (Cognition Therapeutics, Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Inhibikase Pharma (IKT)|P/S multiplikatori SAVA|P/S multiplikatori assertiotx.com (ASRT)|Narxning daromadga nisbati Coya Therapeutics COYA|VistaGen Therapeutics, Inc. - Narxning daromadga nisbati|OVID - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Acumen Pharmaceuticals, Inc ABOS|CRVO: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Alterity Therapeutics Limited|Narxning daromadga nisbati Clene Inc|PepGen Corp - Narxning sotuvga nisbati|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|RLMD (Relmada Corp) - Bozor kapitallashuvining daromadga nisbati|Annovis Bio, Inc. - Kapitalizatsiyaning daromadga nisbati|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (Klotho Neurosciences Inc) - Kapitalizatsiya va daromad nisbati|NRSN: P/S multiplikatori|Sotuvga nisbatan narx Reviva Pharmaceuticals, Inc. (RVPH)|Kapitalizatsiyaning daromadga nisbati MTVA|P/S multiplikatori neuraxis.com|Narxning daromadga nisbati Helius Medical (HSDT)|PASG (passagebio.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Neuphoria Therapeutics NEUP|Minerva (NERV) - Sotuvga nisbatan narx|Athira Pharma, Inc. - P/S multiplikatori|addextherapeutics.com (ADXN) - Kapitalizatsiyaning daromadga nisbati|ALZN: P/S multiplikatori|Cyclerion Therapeutics, Inc. (CYCN) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA (Pasithea) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori CRGT|P/S multiplikatori avenuetx.com (ATXI)|Narxning daromadga nisbati BrainStorm Cell Therapeutics BCLI|Cara Therapeutics Inc. - Narxning daromadga nisbati|CHRO: Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Eliem Therapeutics|intracellulartherapies.com (ITCI) - Narxning daromadga nisbati|LBPH - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati MRNS|NKGN (NKGen Biotech Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|Kapitalizatsiyaning daromadga nisbati NRBO (NeuroBo)|SAGE (Sage Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|TRVN (trevena.com) - Narxning sotuvga nisbati|Vigil Neuro - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati WENA (anewmeds.com)|CERE: P/S multiplikatori
